Drug discovery in an academic setting: playing to the strengths.
about
Small-molecule inhibitors of IκB kinase (IKK) and IKK-related kinasesContributions of academic laboratories to the discovery and development of chemical biology toolsAcademic medical product development: an emerging alliance of technology transfer organizations and the CTSA.Mitigating risk in academic preclinical drug discovery.Consortia's critical role in developing medical countermeasures for re-emerging viral infections: a USA perspective.Academic drug discovery: current status and prospects.
P2860
Drug discovery in an academic setting: playing to the strengths.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Drug discovery in an academic setting: playing to the strengths.
@en
type
label
Drug discovery in an academic setting: playing to the strengths.
@en
prefLabel
Drug discovery in an academic setting: playing to the strengths.
@en
P2860
P356
P1476
Drug discovery in an academic setting: playing to the strengths.
@en
P2860
P304
P356
10.1021/ML400012G
P50
P577
2013-01-17T00:00:00Z